Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
Recruiting
Phase 2
Interventional Study
Non-segmental Vitiligo
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The subject understands and voluntarily signs the informed consent form (ICF) and is willing and able to comply with the study protocol.
* The subject is between 18 and 70 years of age (including borderline values) , regardless of gender.
Exclusion Criteria:
* Pregnant or la…
Contacts